Substituted 1,3-cyclopentadione multitarget protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewith

Details for Australian Patent Application No. 2008335156 (hide)

Owner Metaproteomics, LLC

Inventors Bland, Jeffrey S.; Pacioretty, Linda M; Carroll, Brian; Konda, Veera; Tripp, Matthew L.; Babish, John G.; Darland, Gary; Traub, James; Emma, Dennis; Desai, Anu

Agent Pizzeys

Pub. Number AU-A-2008335156

PCT Pub. Number WO2009/076428

Priority 61/012,506 10.12.07 US

Filing date 10 December 2008

Wipo publication date 18 June 2009

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/076428 Priority application(s): WO2009/076428

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008335158-LNG facility employing a heavies enriching stream

2008335152-Collagen-based matrices with stem cells